Literature DB >> 21892014

Attention deficit hyperactivity disorder and the athlete: an American Medical Society for Sports Medicine position statement.

Margot Putukian1, Jeffrey B Kreher, David B Coppel, James L Glazer, Douglas B McKeag, Russell D White.   

Abstract

Attention deficit hyperactivity disorder (ADHD) is an important issue for the physician taking care of athletes since ADHD is common in the athletic population, and comorbid issues affect athletes of all ages. The health care provider taking care of athletes should be familiar with making the diagnosis of ADHD, the management of ADHD, and how treatment medications impact exercise and performance. In this statement, the term "Team Physician" is used in reference to all healthcare providers that take care of athletes. These providers should understand the side effects of medications, regulatory issues regarding stimulant medications, and indications for additional testing. This position statement is not intended to be a comprehensive review of ADHD, but rather a directed review of the core issues related to the athlete with ADHD.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21892014     DOI: 10.1097/JSM.0b013e3182262eb1

Source DB:  PubMed          Journal:  Clin J Sport Med        ISSN: 1050-642X            Impact factor:   3.638


  17 in total

1.  Inter-association recommendations for developing a plan to recognize and refer student-athletes with psychological concerns at the collegiate level: an executive summary of a consensus statement.

Authors:  Timothy L Neal; Alex B Diamond; Scott Goldman; David Klossner; Eric D Morse; David E Pajak; Margot Putukian; Eric F Quandt; John P Sullivan; Cory Wallack; Victor Welzant
Journal:  J Athl Train       Date:  2013 Sep-Oct       Impact factor: 2.860

2.  Interassociation recommendations for developing a plan to recognize and refer student-athletes with psychological concerns at the secondary school level: a consensus statement.

Authors:  Timothy L Neal; Alex B Diamond; Scott Goldman; Karl D Liedtka; Kembra Mathis; Eric D Morse; Margot Putukian; Eric Quandt; Stacey J Ritter; John P Sullivan; Victor Welzant
Journal:  J Athl Train       Date:  2015-03-02       Impact factor: 2.860

Review 3.  Considerations in the Use of Stimulants in Sport.

Authors:  Claudia L Reardon; Robert M Factor
Journal:  Sports Med       Date:  2016-05       Impact factor: 11.136

Review 4.  Evidence-Based Considerations and Recommendations for Athletic Trainers Caring for Patients With Attention-Deficit/Hyperactivity Disorder.

Authors:  Elizabeth S Wolfe; Kelly J Madden
Journal:  J Athl Train       Date:  2016-11-11       Impact factor: 2.860

5.  Neurodevelopmental Disorders and Risk of Concussion: Findings from the National Collegiate Athletic Association Department of Defense Grand Alliance Concussion Assessment, Research, and Education (NCAA-DOD CARE) Consortium (2014-2017).

Authors:  Brett S Gunn; Thomas W McAllister; Michael A McCrea; Steven P Broglio; R Davis Moore
Journal:  J Neurotrauma       Date:  2022-01-31       Impact factor: 5.269

Review 6.  Factors Influencing Clinical Correlates of Chronic Traumatic Encephalopathy (CTE): a Review.

Authors:  Breton M Asken; Molly J Sullan; Aliyah R Snyder; Zachary M Houck; Vaughn E Bryant; Loren P Hizel; Molly E McLaren; Duane E Dede; Michael S Jaffee; Steven T DeKosky; Russell M Bauer
Journal:  Neuropsychol Rev       Date:  2016-08-25       Impact factor: 7.444

7.  The Use of Stimulant Medication to Treat Attention-Deficit/Hyperactivity Disorder in Elite Athletes: A Performance and Health Perspective.

Authors:  Annie A Garner; Ashley A Hansen; Catherine Baxley; Michael J Ross
Journal:  Sports Med       Date:  2018-03       Impact factor: 11.136

8.  Do Athletes Have More of a Cognitive Profile with ADHD Criteria than Non-Athletes?

Authors:  Elizabeth Ekman; Arto Hiltunen; Henrik Gustafsson
Journal:  Sports (Basel)       Date:  2021-05-11

9.  Prescription stimulants in individuals with and without attention deficit hyperactivity disorder: misuse, cognitive impact, and adverse effects.

Authors:  Shaheen E Lakhan; Annette Kirchgessner
Journal:  Brain Behav       Date:  2012-07-23       Impact factor: 2.708

Review 10.  Stimulant Therapy Utilization for Neurocognitive Deficits in Mild Traumatic Brain Injury.

Authors:  Eric E Coris; Byron Moran; Kevin Sneed; Gianluca Del Rossi; Bradford Bindas; Shaan Mehta; Dusty Narducci
Journal:  Sports Health       Date:  2021-07-22       Impact factor: 4.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.